Experiments

Cloning and Expression System

For our experimentation, expression of MAM7 was done by using our chassis– E.coli BL21 and the vector pET-22b(+).

MAM7 cloning
Fig 1: MAM7 cloning and expression vector system [1]

With our progress in the project, our Wet Lab geared up on a detailed itinerary of planned experiments. This curated handbook includes various experiments like plasmid isolation, competent cell preparation, Ni-NTA column chromatography, etc. The primary objective is to help other iGEM teams carry out these recombinant experiments and provide them with the opportunity to improve their current experimental designs.

With our progress in the project, our Wet Lab geared up on a detailed itinerary of experiments ready to go ahead with. Unfortunately due to lack of time we could not execute the lab work as planned. The Contribution page consists of our experimentation handbook and a lab bulletin that summarises our journey so far in the lab. We curated a handbook such that anyone could refer to it in order to gain a better understanding of our experimentation itinerary. In case anyone happens to pick a project in the same trajectory as ours, this could serve as a guide for them. This handbook has a variety of experiments that we have performed and plan on performing further like—plasmid isolation, peptide purification. Despite our iGEM season coming to an end soon enough, we intend to try to continue our experimentation.

Experimentation Timeline

Here's our week wise experimentation timeline!


Biosafety

Given the conversations we had with the experts in domains like Biosafety and Biosecurity, we decided to not work with the risk-2 organism Vibrio parahaemolyticus. Instead, we decided on expressing our target protein– MAM7 in our chassis– E. coli and performing further experiments with it. Here we are making use of the truncated version of MAM7, lacking the first 44 amino acids which are required for its membrane localization in its pathogenic origin. Thereby the modified MAM7, when heterologously expressed in E. coli, will not be able to mediate any harmful effects. This allowed us to avoid the risks of disease transmission to human beings and environmental dissemination, while complying with the laws and regulations of recombinant research provided by the university.

Further, in order to gain some on-sight experience, we visited Dr. Mamatha Ballal’s lab i.e., the Enteric Diseases Division. Here we were provided with the opportunity to witness the culturing and maintenance of V. parahaemolyticus stocks in a supervised environment.

References

[1] Benchling [Biology Software]. (2022). Retrieved from https://benchling.com.